Neuros Medical, developer of the Altius System for treating chronic post-amputation pain, appointed Thomas Tovello as CFO. Tovello joins the company from Edwards Lifesciences, where he arrived through the company’s acquisition of Endotronix. At Endotronix, he served as senior vice president of finance and administration and played a pivotal role in positioning the company for its acquisition by Edwards. Tovello brings expertise in mergers and acquisitions, capital formation, and financial strategy.
“Tom is an outstanding addition to the Neuros leadership team,” said David Veino, president and CEO. “His tremendous experience and background in growth-stage med-tech, combined with his collaborative, thought-partnership style, make him exactly the right leader to help guide our next chapter.
“As we scale commercial adoption of Altius and expand access for the amputee community, we need a financial leader who understands both the discipline required to build durable systems and the vision required to seize the right strategic moments.”
